Heron Therapeutics' GAAP loss for 2021 was $220.683 million, down 2.9% from $227.278 million in the prior year. Revenue declined 2.6% to $86.346 million from $88.638 million a year earlier.
Heron Therapeutics' GAAP loss for 2021 was $220.683 million, down 2.9% from $227.278 million in the prior year. Revenue declined 2.6% to $86.346 million from $88.638 million a year earlier. 
ir.herontx.com
English (US) 